PropertyValue
?:abstract
  • In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.
is ?:annotates of
?:creator
?:doi
  • 10.1007/s00508-020-01776-w
?:doi
?:journal
  • Wien_Klin_Wochenschr
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/50ce5ac03539e10e59b95bd5085733127ab1cc8b.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7722244.xml.json
?:pmcid
?:pmid
?:pmid
  • 33289854.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
?:type
?:year
  • 2020-12-08

Metadata

Anon_0  
expand all